Thu. 9 May 2024, 5:20pm ET
Benzinga
Earnings, Earnings Beats, News
Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.72) by 9.72 percent. This is a 15.58 percent increase over losses of $(0.77) per share from the same period last year.